Modular Ultrasonic Beacon System (MUBS) for Ultrasound-guided Interventional Surg
Modular Ultrasonic Beacon System (MUBS) for Ultrasound-guided Interventional Surg
批准号:
8589815
负责人:
Thomas Cummins
金额:
$20.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-15 至 2015-01-31
关键词:
AdoptionAlgorithmsBackBiopsyBreastCaringCost SavingsCustomDataDetectionDevicesDistalDropsElectronicsEquilibriumFailureFosteringFutureGenerationsGoalsHealthcare SystemsHousingImageImage EnhancementImageryInterventionLearningLegal patentLocationManufacturer NameMedicalMedical DeviceMethodsModalityMonitorNeedle biopsy procedureNeedlesNerve BlockOperative Surgical ProceduresPhasePhysiologic pulsePlayPower SourcesPrintingProblem SolvingProceduresProviderResearchResearch PersonnelRiskSafetySamplingSchemeSignal TransductionSolutionsSystemTissuesTrainingTransducersUltrasonic TherapyUltrasonic TransducerUltrasonicsUltrasonographyUnnecessary SurgeryWomananalogbasebreast cancer diagnosiscommercializationcomputerized data processingcostcost effectivenessdesignhazardimaging probeinnovationinnovative technologiesmanufacturing processminiaturizeminimally invasivenovelpatient safetyprototypepublic health relevancesoft tissuestandard of caretool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Each year 1.6 million US women undergo biopsy for breast cancer diagnosis. Fortunately fewer and fewer women suffer through open surgical biopsy but rather receive minimally invasive image-guided needle based biopsy. Ultrasound imaging guidance is the dominant modality for this intervention as it offers the greatest balance of safety, patient comfort, expediency, and cost effectiveness. However, for all its safety and convenience, ultrasound imaging quality remains strongly operator dependent. This problem is exacerbated by the fact that ultrasound is optimal for imaging soft tissue and not metallic tools such as needles. What this presents is a new barrier for adoption amongst many would-be practitioners: ultrasound guided needle-based interventions are difficult and require substantial training. ClariTrac Inc. is a startup medical device company that aims to solve this problem. Specifically, ClariTrac is developing a patent pending Modular Ultrasonic Beacon System (MUBS) that consists mainly of a disposable, miniature hardware component to be incorporated with the tip or shaft of needles or other interventional tools. The MUBS is a fully integrated ultrasound transducer with electronics and interconnection. The operating principle of the MUBS is like a beacon: it waits in stand-by to detect ultrasound energy emitted from the ultrasound imaging probe. Upon detecting the probe's energy, the MUBS in turn actively transmits energy back to the probe, in a marco-polo fashion. This returned energy appears as a bright, customizable marker on the ultrasound image that represents the precise location of the interventional tool. We hypothesize this marker will allow the care- provider to perform the procedure with greater ease and precision. Our ultimate goal is to design hardware that serves as a low-cost platform for future innovation in ultrasound enabled interventional tools. These applications extend to nerve block and line-placement, beyond image enhancement to imaging, tissue characterization, monitoring and therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金